MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
993.34%
Quick Ratio
993.34%
Cash Ratio
298.67%
Debt to Asset Ratio
64.79%
Unit: Thousand (K) dollars
Assets Breakdown
    • Short-term investments
    • Cash and cash equivalents
    • Long-term investments
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Convertible senior notes, net
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
196,577
500,224
110,641
115,565
Short-term investments
446,549
216,981
232,551
175,319
Prepaid expenses and other current assets
10,668
12,959
7,979
5,758
Total current assets
653,794
730,164
351,171
296,642
Property and equipment, net
23
28
34
50
Operating lease right-of-use assets, net
821
1,090
1,354
807
Long-term investments
30,763
1,340
17,272
10,717
Other non-current assets
16,289
15,060
13,809
13,802
Total assets
701,690
747,682
383,640
322,018
Accounts payable
7,589
8,944
7,111
6,444
Accrued expenses
57,406
51,180
54,423
45,359
Operating lease liabilities, current
823
1,037
1,115
618
Total current liabilities
65,818
61,161
62,649
52,421
Royalty obligation
91,737
84,900
-
-
Senior secured term loan, net
74,060
72,084
-
-
Royalty obligation
-
-
78,636
72,989
Convertible senior notes, net
222,956
193,631
-
-
Operating lease liabilities, less current portion
22
77
211
180
Total long-term liabilities
388,775
350,692
78,847
73,169
Total liabilities
454,593
411,853
141,496
125,590
Common stock, par value 0.0001 per share 175,000,000 shares authorized at june 30, 2026 and december 31, 2025, respectively 63,330,747 and 54,485,518 shares issued and outstanding as of june 30, 2026 and december 31, 2025, respectively
6
6
5
4
Additional paid-in capital
1,205,803
1,182,315
1,007,331
721,179
Accumulated other comprehensive loss
-1,141
-377
-64
-69
Accumulated deficit
-957,571
-846,115
-765,128
-524,686
Total stockholders' equity
247,097
335,829
242,144
196,428
Total liabilities and stockholders' equity
701,690
747,682
383,640
322,018
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Short-term investments$446,549K (94.77%↑ Y/Y)Cash and cashequivalents$196,577K (346.70%↑ Y/Y)Prepaid expenses andother current assets$10,668K (100.38%↑ Y/Y)Total current assets$653,794K (134.67%↑ Y/Y)Long-term investments$30,763K (1806.01%↑ Y/Y)Other non-currentassets$16,289K (38.08%↑ Y/Y)Operating leaseright-of-use assets, net$821K (-18.71%↓ Y/Y)Property and equipment,net$23K (-62.30%↓ Y/Y)Total assets$701,690K (139.42%↑ Y/Y)Total liabilities andstockholders' equity$701,690K (139.42%↑ Y/Y)Total liabilities$454,593K (750.36%↑ Y/Y)Total stockholders'equity$247,097K (3.12%↑ Y/Y)Accumulated deficit-$957,571K (-102.37%↓ Y/Y)Accumulated othercomprehensive loss-$1,141K (-1113.83%↓ Y/Y)Total long-termliabilities$388,775K Total currentliabilities$65,818K (23.62%↑ Y/Y)Additional paid-in capital$1,205,803K (69.14%↑ Y/Y)Common stock, par value0.0001 per share...$6K (50.00%↑ Y/Y)Convertible senior notes,net$222,956K Royalty obligation$91,737K Senior secured termloan, net$74,060K Operating leaseliabilities, less current...$22K (-89.77%↓ Y/Y)Accrued expenses$57,406K (28.94%↑ Y/Y)Accounts payable$7,589K (-4.31%↓ Y/Y)Operating leaseliabilities, current$823K (3.78%↑ Y/Y)

Zenas BioPharma, Inc. (ZBIO)

Zenas BioPharma, Inc. (ZBIO)